Carcinoma - Drug therapy
Research News and Information

Sunday, November 22, 2009

De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system.

13 Dec 2009 We present a case of a 14-year-old male with a germline TP53 mutation who presented with synchronous primitive neuroectodermal tumor and choroid plexus carcinoma. Identification of synchronous brain tumors prompted genetic testing for predisposition ... Read more...

[Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel]

29 Sep 2009 To develop a treatment strategy for peritoneal carcinomatosis using a combination of extended peritoneal resections, local destructive procedures and hyperthermic intraperitoneal chemotherapy creates great concern between healthcare workers involved ... Read more...

Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study.

12 Sep 2009 AIM: To evaluate the efficacy and the safety of combined 5-Fluorouracil, irinotecan, bevacizumab and sirolimus in refractory advanced colorectal carcinoma. METHODS: We initiated a regimen with at day 1 an injection (iv) of bevacizumab at 5 mg/kg, ... Read more...

Latest indexed articles for 'Carcinoma - Drug therapy'

These are the very latest articles for this heading:

• De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. 13 Dec 2009
• [Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel] 29 Sep 2009
• Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study. 12 Sep 2009
• [A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab] 30 Aug 2009
• Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer. 30 Aug 2009
• A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. 22 Aug 2009
• Chemotherapy alone for glottic carcinoma: a need for higher-level evidence. 30 Jul 2009
• Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. 30 Jul 2009
• Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo. 26 Jul 2009
• Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. 25 Jul 2009
• Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines. 21 Jul 2009
• Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope. 15 Jul 2009
• "Clickable" polymer-caged nanobins as a modular drug delivery platform. 6 Jul 2009
• Docetaxel and gemcitabine in the treatment of metastatic breast carcinoma: a dose finding study. 29 Jun 2009
• Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis. 29 Jun 2009
• Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. 21 Jun 2009
• Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes. 14 Jun 2009
• [Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience] 10 Jun 2009
• Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. 7 Jun 2009
• Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. 7 Jun 2009

See a longer list of these articles.

Technical information about 'Carcinoma'

Definition: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)

Descriptor UI: D002277

Alternative terms: Carcinoma; Carcinomas; Epithelial Neoplasms, Malignant; Malignant Epithelial Neoplasms; Epithelial Neoplasm, Malignant; Malignant Epithelial Neoplasm; Neoplasm, Malignant Epithelial; Neoplasms, Malignant Epithelial; Epithelial Tumors, Malignant; Epithelial Tumor, Malignant; Malignant Epithelial Tumor; Malignant Epithelial Tumors; Tumor, Malignant Epithelial; Tumors, Malignant Epithelial; Epithelioma; Epitheliomas; Carcinomatosis; Carcinomatoses; Carcinoma, Undifferentiated; Carcinomas, Undifferentiated; Undifferentiated Carcinoma; Undifferentiated Carcinomas; Carcinoma, Anaplastic; Anaplastic Carcinoma; Anaplastic Carcinomas; Carcinomas, Anaplastic; Carcinoma, Spindle-Cell; Carcinoma, Spindle Cell; Carcinomas, Spindle-Cell; Spindle-Cell Carcinoma; Spindle-Cell Carcinomas;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.557.470.200;

Technical Notes: do not use for "cancer" routinely: use only for carcinoma as a histological type: Manual 24.2.1.3; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); X ref CARCINOMA, ANAPLASTIC: do not coord with ANAPLASIA unless anaplasia is particularly discussed